Novelda

Carnegie Investment Bank Norway is proud to have acted as financial advisor to NOVELDA in connection with the successful NOK 400 million private placement.

In addition to strong support from existing shareholders, the transaction attracted strong interest from tier 1 institutional investors and was covered on indications receiving during the pre-sounding. As part of the transaction NOVELDA has provided a board resolution to initiate a process towards a listing of the Company’s shares on the Oslo Stock Exchange within 12 months.

The net proceeds will be used to finance the further development of the company’s technology, scaling of the organization and general corporate purposes.

Carnegie congratulates Jan-Bjørnar LundHenrik Rosenlund and rest of the NOVELDA team with the successful transaction and we look forward to continuing our support of NOVELDA going forward.

Link to press release: https://lnkd.in/gy9m-U9q

Related articles

SpinChip Diagnostics ASA
Investment Banking

SpinChip Diagnostics ASA

Carnegie Investment Bank is proud to have acted as Joint Bookrunner in connection with SpinChip Diagnostics ASA’...

Navamedic ASA
Investment Banking

Navamedic ASA

Carnegie Investment Bank acted as Joint Bookrunner in connection with the NOK 95 million placing of...